Western blot analysis evidenced a strong increase in p-AKT and a strong decrease in cleaved CASP3 in Aβ vs. SFN5 + Aβ (Figure 7), confirming that SFN pre-treatment stimulated the PI3K-AKT pathway and inhibited apoptosis in the AD model. This evidence concerns the gene CASP3 and Alzheimer disease.